Research Site — Birmingham, Alabama

Public research footprint of Research Site, compiled from the ClinicalTrials.gov public registry.

1,167

Registered studies

323

Active

138

Recruiting now

682

Completed

155

Stopped or withdrawn

Most-studied conditions

Diffuse Large B-Cell Lymphoma · Chronic Obstructive Pulmonary Disease · Idiopathic Pulmonary Fibrosis · Heart Failure

Recently updated registry entries

NCT03459846 — A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible… (Active Not Recruiting)
NCT04613596 — Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase… (Recruiting)
NCT04929236 — Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Research Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.